Supernus annual meeting results: directors elected, equity plan increase approved

SUPERNUS PHARMACEUTICALS, INC.

Class III directors Georges Gemayel and Bethany Sensenig elected with ~48.4M and ~48.6M votes for, respectively.
Say-on-pay proposal approved with 48.2M for, 2.3M against, 1.9M broker non-votes.
Ratification of KPMG as auditor passed with 52.2M for, 272.9K against; no broker non-votes.
Amendment to 2021 Equity Incentive Plan to increase shares passed with 45.5M for, 5.0M against, 1.9M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.